Ask HopeStage to review this study with me
Leave your email and HopeStage can help you better understand this study.
Study reference: NCT07501728. HopeStage can help you review the study, but cannot decide medical eligibility.
Not Yet RecruitingNCT07501728
Intranasal Dexmedetomidine for Postpartum Depression Prevention
This study is not yet recruiting. It focuses on depression and currently lists study information in China.
DepressionOtherOver 18 Years
Key information made simple
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve attention, thinking, or day-to-day functioning. For people living with Depression, being understood earlier and more clearly can shape the whole care journey. If the findings are useful, they could help shape larger studies and better designed support in the future. Taking part helps build the evidence that can improve understanding and care for others over time.
Your next step
The official record suggests in-person participation through a hospital, with sites including Chengdu Jinjiang District Women & Children Health Hospital, in Chengdu. Participation appears to involve assessments along with scans or samples to help researchers understand patterns more clearly. The main fit is usually meeting the main study requirements, while common reasons not to take part include safety concerns that need urgent care first and active substance or alcohol problems that could affect the results. The official record does not list a formal phase, which usually means this is focused more on feasibility, delivery, or support than a standard drug-development stage.
Questions to ask before joining
- What are the exact eligibility criteria, and what could exclude someone?
- How many visits, assessments, or follow-ups are expected, and over what period?
- What risks, side effects, practical burdens, or alternatives should be understood first?
- Who should be contacted to confirm locations, timing, compensation, and next steps?
Things to check before joining
- Sponsor
- Chengdu Jinjiang Maternity and Child Health Hospital
- Sponsor type
- Hospital / academic medical center
- Main activity
- digital app or tool
- Intervention
- Not available
- Time commitment
- long follow-up or multiple visits
- Study phase
- Not available
- Enrollment
- Not available
- Recruitment status
- Not Yet Recruiting
- Source
- Official registry link
Key study information
- Official title
- Intranasal Dexmedetomidine for Postpartum Depression Prevention
- Condition
- Postpartum Depression (PPD)
- Study status
- Not Yet Recruiting
- Sponsor / lead affiliation
- Chengdu Jinjiang Maternity and Child Health Hospital
- Location / country
- China
- Registry
- ClinicalTrials.gov
- External trial ID
- NCT07501728
Why this study may matter
This study may matter because it adds public evidence around depression. HopeStage presents it as a starting point for understanding the study, checking the official source, and preparing questions with a care team.
For you
Taking part may help clarify how this condition is measured or understood.
It requires regular visits and structured follow-up.
Requires travel, with in-person participation in China.
Registry reference
This page links back to the public source record so people can verify details directly with the registry and research team.
If you want the full study description, eligibility criteria, locations, and sponsor information in the original format, this is the place to check before taking the next step.
- Official title
- Intranasal Dexmedetomidine for Postpartum Depression Prevention
- Source
- ClinicalTrials.gov
- Official registry link
- Open official registry
- External trial ID
- NCT07501728
Not medical advice
Information from public sources. Are you the study sponsor? Contact us to update this page: hi@hopestage.com
Questions about this study
What is Intranasal Dexmedetomidine for Postpartum Depression Prevention?
This study is exploring digital app or tool for people with depression. Participants may complete study visits, assessments, or follow-up activities defined by the research team. Direct benefit is not guaranteed.
Who is behind this study, and what type of sponsor is it?
This study is sponsored by Chengdu Jinjiang Maternity and Child Health Hospital. Based on the sponsor name or official registry information, it appears to be a hospital or academic medical center. You should verify the details in the official registry record.
What does participation involve, what phase is it, and what should I ask about safety?
This study may involve digital app or tool, study visits, and assessments. The time commitment is long follow-up or multiple visits. The study phase is not available in HopeStage data. Check the official source record to see whether a phase is listed. Enrollment is not available in HopeStage data. HopeStage cannot say whether a study is safe or right for you. Before joining, ask the research team about possible risks, time commitment, visits, side effects, compensation, safety monitoring, and whether participation may affect your current care.
Where can I verify the study details?
Use the official source record linked on this page to check the full study description, recruitment status, eligibility criteria, locations, sponsor information, phase, enrollment, contact details, and any listed risks or requirements.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me